These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 4199963

  • 21. [Standarization of therapy in hemaoblastoses and malignant lymphomas as shown on the sample of lymphogranulomatosis].
    Fleischer J.
    Z Gesamte Inn Med; 1973 Apr 15; 28(8):125-7. PubMed ID: 4197807
    [No Abstract] [Full Text] [Related]

  • 22. Recent advances in chemotherapy of lymphoma.
    Lenhard RE, Owens AH.
    Johns Hopkins Med J; 1967 Aug 15; 121(2):136-40. PubMed ID: 5340335
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Chemotherapy of lymphogranulomatosis].
    Schmidt CG.
    Internist (Berl); 1974 Feb 15; 15(2):93-102. PubMed ID: 4600311
    [No Abstract] [Full Text] [Related]

  • 26. Clinical experience with ibenzmethyzin (Natulan) in the treatment of lymphomas and solid tumours.
    Holsti LR, Hjelt AL.
    Ann Med Intern Fenn; 1967 Feb 15; 56(3):119-24. PubMed ID: 5630600
    [No Abstract] [Full Text] [Related]

  • 27. [The role of vinblastine in the treatment of malignant lymphomas].
    Eridani S, Esposito R, Ponti GB, Giangrande A.
    Cancro; 1968 Feb 15; 21():Suppl 6:102+. PubMed ID: 4906143
    [No Abstract] [Full Text] [Related]

  • 28. [Experience with polychemotherapy of generalized forms of lymphogranulomatosis].
    Kondrat'eva AP.
    Klin Med (Mosk); 1972 Oct 15; 50(10):123-30. PubMed ID: 4656236
    [No Abstract] [Full Text] [Related]

  • 29. Use of vinblastine for maintenance therapy in malignant lymphomas.
    Klener P, Donner L, Ort J.
    Neoplasma; 1974 Oct 15; 21(3):323-9. PubMed ID: 4608740
    [No Abstract] [Full Text] [Related]

  • 30. Long-term outcome of children and adolescents treated with the COPP-ABV hybrid protocol for Hodgkin's disease: balance of risks.
    Klumb CE, Carriço MK, de Rezende LM, Byington R, Bordallo MA, Bigni RS, Apa AG, Dobbin JA.
    Clin Oncol (R Coll Radiol); 2007 Oct 15; 19(8):628-9. PubMed ID: 17662581
    [No Abstract] [Full Text] [Related]

  • 31. [Polychemotherapy of cancers].
    Jacquillat C.
    Rev Stomatol Chir Maxillofac; 1974 Oct 15; 75(1):175-8. PubMed ID: 4531685
    [No Abstract] [Full Text] [Related]

  • 32. [Experience with combined drug therapy of Hodgkin's disease, using chlorambucil, vinblastine, procarbazine and prednisolone].
    Berényi E, Dankó K, Szegedi G.
    Orv Hetil; 1980 Mar 17; 121(10):571-3. PubMed ID: 7366965
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Chemotherapy of lymphoma with mechlorethamine and vinblastine.
    Solomon J, Jacobs EM, Bateman JR, Lukes RJ, Weiner JM, Donohue DM.
    Arch Intern Med; 1973 Mar 17; 131(3):407-17. PubMed ID: 4569376
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Secondary tumors in hemoblastoses during cytostatic treatment].
    Hartwich G, Butzler W.
    Med Klin; 1971 Oct 22; 66(43):1445-50. PubMed ID: 5001553
    [No Abstract] [Full Text] [Related]

  • 38. [Treatment of Hodgkin's disease].
    Brule G.
    Arq Patol; 1974 Oct 22; 46(2-3):273-7. PubMed ID: 4458640
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.